Kineret (anakinra) - SOBI
Jakafi (ruxolitinib) - Incyte
etoposide IV - Generic mfg.
Lymphoma-Associated Hemophagocytic Lymphohistiocytosis: A Tertiary Centre Experience in Saudi Arabia (SOHO 2026) - Sep 1, 2026 - Abstract #ABCL-122; "All patients received steroids and chemotherapy appropriate to their diagnoses: 5 patients received anakinra and immunoglobulins, 4 received etoposide, and 1 received ruxolitinib. Six patients were male, and 1 was female. All 6 male patients were young, with an average age of 29.7 years, and the female patient was 73 years. Histological diagnosis: diffuse large B-cell lymphoma, 4 patients; Hodgkin lymphoma, 2 patients; and T-cell lymphoma, 1 patient." 
B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Hematological Malignancies • Hodgkin Lymphoma • Lymphoma • Non-Hodgkin's Lymphoma • Oncology • T Cell Non-Hodgkin Lymphoma • IL2RA • ISG20
https://www.sciencedirect.com/science/article/abs/pii/S2152265026025322
 
Nagah Elmusharaf MBBS,MRCP(UK),FRCPath(UK); Nouf Albalawi MBBS; Raneem Alraheili MBBS; Adel Alnakhli PharmD,BCOP,BCPS; Zeyad Alshaibani MBBS; Mohammed Almakadi MBBS; Amal Albeihany MD
 
Sep 1, 2026
 
Prev Next